Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) traded down 1.5% during mid-day trading on Monday . The stock traded as low as $0.32 and last traded at $0.36. 4,880 shares traded hands during mid-day trading, a decline of 75% from the average session volume of 19,397 shares. The stock had previously closed at $0.36.
Alpha Tau Medical Stock Down 1.5%
The firm’s 50 day moving average is $0.28 and its 200-day moving average is $0.25.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Further Reading
- Five stocks we like better than Alpha Tau Medical
- Where to Find Earnings Call Transcripts
- Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300
- Investing In Automotive Stocks
- Cathie Wood Buys Alibaba and Baidu: Momentum or More Value Ahead?
- Stock Sentiment Analysis: How it Works
- This ETF Weeds Out Small-Cap Underperformers
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
